A. “Optimization of Genome Editing Therapeutics for Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD) (U01 – Clinical Trials Not Allowed),” (RFA-NS-23-017, National Institute on Aging, in conjunction with other agencies, application deadline Nov. 30, 2022).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-017.html
B. “HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed),” (RFA-EB-22-002, National Institute on Aging, in conjunction with other agencies, application deadlines Nov. 14, 2022, June 19, 2023, Feb. 20, 2024, Oct. 15, 2024, June 17, 2025).
grants.nih.gov/grants/guide/rfa-files/RFA-EB-22-002.html
C. “NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed),” (PAR-22-227, a reissue of RFA-AG-22-004, National Institute on Aging, application deadlines Nov. 15, 2022, Oct. 18, 2023, and Oct. 17, 2024). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed),” (PAR-22-226).
